PRIZMAH Trademark

Trademark Overview


On Friday, August 18, 2017, a trademark application was filed for PRIZMAH with the United States Patent and Trademark Office. The USPTO has given the PRIZMAH trademark a serial number of 87574916. The federal status of this trademark filing is REGISTERED as of Tuesday, April 2, 2019. This trademark is owned by AK Pharma, Inc.. The PRIZMAH trademark is filed in the Medical Instrument Products category with the following description:

Medical apparatus and instruments, namely, platelet rich plasma extraction kit comprising syringes, blood component separation apparatus and sample tubes containing anticoagulant
prizmah

General Information


Serial Number87574916
Word MarkPRIZMAH
Filing DateFriday, August 18, 2017
Status700 - REGISTERED
Status DateTuesday, April 2, 2019
Registration Number5716579
Registration DateTuesday, April 2, 2019
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 17, 2018

Trademark Statements


Description of MarkThe mark consists of a triangle design composed of identical circles that curve to the left side of the stylized word "PRIZMAH".
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesMedical apparatus and instruments, namely, platelet rich plasma extraction kit comprising syringes, blood component separation apparatus and sample tubes containing anticoagulant

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, August 24, 2017
Primary Code010
First Use Anywhere DateWednesday, June 3, 2015
First Use In Commerce DateWednesday, May 16, 2018

Trademark Owner History


Party NameAK Pharma, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMiami, FL 33186

Party NameAK Pharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMiami, FL 33186

Party NameAK Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMiami, FL 33186

Trademark Events


Event DateEvent Description
Tuesday, April 2, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, April 2, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, February 27, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
Tuesday, February 26, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, February 26, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Monday, February 25, 2019STATEMENT OF USE PROCESSING COMPLETE
Friday, February 22, 2019USE AMENDMENT FILED
Monday, February 25, 2019SOU EXTENSION 1 GRANTED
Wednesday, December 12, 2018SOU EXTENSION 1 FILED
Saturday, February 23, 2019NOTICE OF REVIVAL - MAILED
Friday, February 22, 2019SOU EXTENSION RECEIVED WITH TEAS PETITION
Friday, February 22, 2019PETITION TO REVIVE-GRANTED
Friday, February 22, 2019TEAS PETITION TO REVIVE RECEIVED
Friday, February 22, 2019TEAS STATEMENT OF USE RECEIVED
Wednesday, February 13, 2019ABANDONMENT NOTICE MAILED - DEFECTIVE USE STATEMENT
Wednesday, February 13, 2019ABANDONMENT - DEFECTIVE USE STATEMENT
Friday, September 7, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 9, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, June 12, 2018NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 17, 2018PUBLISHED FOR OPPOSITION
Wednesday, March 28, 2018NOTICE OF PUBLICATION
Thursday, March 8, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 8, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 7, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 7, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 24, 2017NON-FINAL ACTION MAILED
Wednesday, November 22, 2017NON-FINAL ACTION WRITTEN
Wednesday, November 22, 2017ASSIGNED TO EXAMINER
Friday, August 25, 2017NOTICE OF DESIGN SEARCH CODE MAILED
Thursday, August 24, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED